Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia - PubMed (original) (raw)

Guideline

Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia

American Thoracic Society et al. Am J Respir Crit Care Med. 2005.

No abstract available

PubMed Disclaimer

Comment in

• Adult hospital and ventilator-associated pneumonia guidelines: eminence- rather than evidence-based.
  Silvestri L, van Saene HK, de la Cal MA, Gullo A. Silvestri L, et al. Am J Respir Crit Care Med. 2006 Jan 1;173(1):131-3; author reply 133. doi: 10.1164/ajrccm.173.1.131. Am J Respir Crit Care Med. 2006. PMID: 16368795 No abstract available.

Similar articles

• Therapy of ventilator-associated pneumonia: what more can we do to use less antibiotics?
  Niederman MS. Niederman MS. Crit Care Med. 2004 Nov;32(11):2344-5. doi: 10.1097/01.ccm.0000146138.34857.7c. Crit Care Med. 2004. PMID: 15640653 No abstract available.
• Hospital-acquired pneumonia: diagnostic strategies: lessons from clinical trials.
  Fagon JY. Fagon JY. Infect Dis Clin North Am. 2003 Dec;17(4):717-26. doi: 10.1016/s0891-5520(03)00071-0. Infect Dis Clin North Am. 2003. PMID: 15008594 Review.
• [Etiology and diagnosis of pneumonia in patients on artificial lung ventilation].
  Khrapov KN, Pavlova EA, Kolesnik AV, Eremenko EA. Khrapov KN, et al. Anesteziol Reanimatol. 2001 Jul-Aug;(4):60-2. Anesteziol Reanimatol. 2001. PMID: 11586637 Russian. No abstract available.
• De-escalation therapy in ventilator-associated pneumonia.
  Rello J, Vidaur L, Sandiumenge A, Rodríguez A, Gualis B, Boque C, Diaz E. Rello J, et al. Crit Care Med. 2004 Nov;32(11):2183-90. doi: 10.1097/01.ccm.0000145997.10438.28. Crit Care Med. 2004. PMID: 15640629
• [Ventilator associated pneumonia: risk factors, diagnosis, treatment and prevention].
  Pilvinis V, Stirbiene I. Pilvinis V, et al. Medicina (Kaunas). 2003;39(11):1057-64. Medicina (Kaunas). 2003. PMID: 14646458 Review. Lithuanian.

Cited by

• Major alteration of lung microbiome and the host responses in critically ill COVID-19 patients with high viral load.
  Bustos IG, Wiscovitch-Russo R, Singh H, Sievers BL, Matsuoka M, Freire M, Tan GS, Cala MP, Guerrero JL, Martin-Loeches I, Gonzalez-Juarbe N, Reyes LF. Bustos IG, et al. Sci Rep. 2024 Nov 12;14(1):27637. doi: 10.1038/s41598-024-78992-1. Sci Rep. 2024. PMID: 39532981 Free PMC article.
• Community-Acquired Pneumonia in the Immunocompromised Patients: An Observational Study from a Single Center, TURKEY.
  Yılmaz E, Benli A, Başaran S, Şimşek-Yavuz S, Cagatay A, Oncul MO, Özsüt H, Eraksoy H. Yılmaz E, et al. Infect Drug Resist. 2024 Nov 6;17:4875-4885. doi: 10.2147/IDR.S480520. eCollection 2024. Infect Drug Resist. 2024. PMID: 39524981 Free PMC article.
• Glucose-albumin ratio (GAR) as a novel biomarker for predicting postoperative pneumonia (POP) in older adults with hip fractures.
  Tang W, Ni X, Yao W, Wang W, Li Y, Lv Q, Ding W, He R. Tang W, et al. Sci Rep. 2024 Nov 4;14(1):26637. doi: 10.1038/s41598-024-60390-2. Sci Rep. 2024. PMID: 39496632 Free PMC article.
• The glucocorticoid dose-mortality nexus in pneumonia patients: unveiling the threshold effect.
  Wang S, Ye Q. Wang S, et al. Front Pharmacol. 2024 Sep 19;15:1445979. doi: 10.3389/fphar.2024.1445979. eCollection 2024. Front Pharmacol. 2024. PMID: 39364057 Free PMC article.
• Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia.
  Ryu J, Kim NH, Ohn JH, Lim Y, Lee J, Kim HW, Kim SW, Park HS, Kim ES, Yoon S, Heo E, Kim ES. Ryu J, et al. Sci Rep. 2024 Sep 30;14(1):22669. doi: 10.1038/s41598-024-73304-z. Sci Rep. 2024. PMID: 39349548 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information